Prostate Cancer Therapeutics Market Research Report by Drug Class (Chemotherapy, Hormonal Therapy, Immunotherapy, and Targeted Therapy) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Prostate Cancer Therapeutics Market is expected to grow from USD 8,399.57 Million in 2020 to USD 10,868.64 Million by the end of 2025.
2. The Global Prostate Cancer Therapeutics Market is expected to grow from EUR 7,364.90 Million in 2020 to EUR 9,529.83 Million by the end of 2025.
3. The Global Prostate Cancer Therapeutics Market is expected to grow from GBP 6,547.42 Million in 2020 to GBP 8,472.04 Million by the end of 2025.
4. The Global Prostate Cancer Therapeutics Market is expected to grow from JPY 896,447.79 Million in 2020 to JPY 1,159,960.32 Million by the end of 2025.
5. The Global Prostate Cancer Therapeutics Market is expected to grow from AUD 12,197.30 Million in 2020 to AUD 15,782.72 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Prostate Cancer Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Drug Class, the Prostate Cancer Therapeutics Market studied across Chemotherapy, Hormonal Therapy, Immunotherapy, and Targeted Therapy.
Based on Geography, the Prostate Cancer Therapeutics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Prostate Cancer Therapeutics Market including Astella, Inc., Astrazeneca, Bayer AG, IPSEN, Johnson & Johnson, Sanofi Aventis, and Valent Pharmaceuticals LLC.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Prostate Cancer Therapeutics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Prostate Cancer Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Prostate Cancer Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Prostate Cancer Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Prostate Cancer Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Prostate Cancer Therapeutics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Prostate Cancer Therapeutics Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Prostate Cancer Therapeutics Market is expected to grow from USD 8,399.57 Million in 2020 to USD 10,868.64 Million by the end of 2025.
2. The Global Prostate Cancer Therapeutics Market is expected to grow from EUR 7,364.90 Million in 2020 to EUR 9,529.83 Million by the end of 2025.
3. The Global Prostate Cancer Therapeutics Market is expected to grow from GBP 6,547.42 Million in 2020 to GBP 8,472.04 Million by the end of 2025.
4. The Global Prostate Cancer Therapeutics Market is expected to grow from JPY 896,447.79 Million in 2020 to JPY 1,159,960.32 Million by the end of 2025.
5. The Global Prostate Cancer Therapeutics Market is expected to grow from AUD 12,197.30 Million in 2020 to AUD 15,782.72 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Prostate Cancer Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Drug Class, the Prostate Cancer Therapeutics Market studied across Chemotherapy, Hormonal Therapy, Immunotherapy, and Targeted Therapy.
Based on Geography, the Prostate Cancer Therapeutics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Prostate Cancer Therapeutics Market including Astella, Inc., Astrazeneca, Bayer AG, IPSEN, Johnson & Johnson, Sanofi Aventis, and Valent Pharmaceuticals LLC.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Prostate Cancer Therapeutics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Prostate Cancer Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Prostate Cancer Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Prostate Cancer Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Prostate Cancer Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Prostate Cancer Therapeutics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Prostate Cancer Therapeutics Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, BY DRUG CLASS
6.1. Introduction
6.2. Chemotherapy
6.3. Hormonal Therapy
6.4. Immunotherapy
6.5. Targeted Therapy
7. AMERICAS PROSTATE CANCER THERAPEUTICS MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER THERAPEUTICS MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Astella, Inc.
11.2. Astrazeneca
11.3. Bayer AG
11.4. IPSEN
11.5. Johnson & Johnson
11.6. Sanofi Aventis
11.7. Valent Pharmaceuticals LLC
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, BY DRUG CLASS
6.1. Introduction
6.2. Chemotherapy
6.3. Hormonal Therapy
6.4. Immunotherapy
6.5. Targeted Therapy
7. AMERICAS PROSTATE CANCER THERAPEUTICS MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER THERAPEUTICS MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Astella, Inc.
11.2. Astrazeneca
11.3. Bayer AG
11.4. IPSEN
11.5. Johnson & Johnson
11.6. Sanofi Aventis
11.7. Valent Pharmaceuticals LLC
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. AMERICAS PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. AMERICAS PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. ARGENTINA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. BRAZIL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. CANADA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. MEXICO PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. UNITED STATES PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AUSTRALIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. CHINA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. INDIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. INDONESIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. JAPAN PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. MALAYSIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. PHILIPPINES PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. SOUTH KOREA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. THAILAND PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. FRANCE PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GERMANY PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ITALY PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. NETHERLANDS PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. QATAR PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. RUSSIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. SAUDI ARABIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. SOUTH AFRICA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. SPAIN PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. UNITED ARAB EMIRATES PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. UNITED KINGDOM PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: SCORES
TABLE 41. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 42. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 43. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: RANKING
TABLE 44. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 45. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 46. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 47. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 48. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 49. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. AMERICAS PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. AMERICAS PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. ARGENTINA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. BRAZIL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. CANADA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. MEXICO PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. UNITED STATES PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AUSTRALIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. CHINA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. INDIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. INDONESIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. JAPAN PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. MALAYSIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. PHILIPPINES PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. SOUTH KOREA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. THAILAND PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. FRANCE PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GERMANY PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ITALY PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. NETHERLANDS PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. QATAR PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. RUSSIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. SAUDI ARABIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. SOUTH AFRICA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. SPAIN PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. UNITED ARAB EMIRATES PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. UNITED KINGDOM PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: SCORES
TABLE 41. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 42. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 43. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: RANKING
TABLE 44. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 45. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 46. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 47. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 48. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 49. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 5. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 13. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 15. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 19. AMERICAS PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 20. AMERICAS PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 22. ARGENTINA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 23. BRAZIL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. CANADA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. MEXICO PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. UNITED STATES PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 27. ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 28. ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 30. AUSTRALIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. CHINA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. INDIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. INDONESIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. JAPAN PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. MALAYSIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. PHILIPPINES PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. SOUTH KOREA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. THAILAND PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 40. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 42. FRANCE PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. GERMANY PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. ITALY PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. NETHERLANDS PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. QATAR PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. RUSSIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SAUDI ARABIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SOUTH AFRICA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. SPAIN PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. UNITED ARAB EMIRATES PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. UNITED KINGDOM PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 54. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 55. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 56. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, BY TYPE
FIGURE 1. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 5. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 13. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 15. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 19. AMERICAS PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 20. AMERICAS PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 22. ARGENTINA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 23. BRAZIL PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. CANADA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. MEXICO PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. UNITED STATES PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 27. ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 28. ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 30. AUSTRALIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. CHINA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. INDIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. INDONESIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. JAPAN PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. MALAYSIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. PHILIPPINES PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. SOUTH KOREA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. THAILAND PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 40. EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 42. FRANCE PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. GERMANY PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. ITALY PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. NETHERLANDS PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. QATAR PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. RUSSIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SAUDI ARABIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SOUTH AFRICA PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. SPAIN PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. UNITED ARAB EMIRATES PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. UNITED KINGDOM PROSTATE CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 54. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 55. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 56. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, BY TYPE
